← Weekly issues
Week of 2026-09-21
2026-W39 · 2026-09-21 – 2026-09-27 · 152 findings
review
The mechanisms and mechanics of aging.
Aging tissue stiffening, fragility, poor regeneration and chronic inflammation emerge from progressive failure of mechanotransduction across an ECM–integrin–cytoskeleton–nucleus axis, motivating strategies to reset the aged mechanochemical niche.
review
Cardiovascular frailty - an emerging frailty phenotype.
Cardiovascular frailty should be recognized as a distinct frailty phenotype integrating blood-pressure dynamics, vascular ageing, and oxi-inflammaging that bidirectionally links frailty with cardiovascular morbidity and mortality.
observational
Loneliness and all-cause mortality in the United States.
Clinically documented loneliness was independently associated with higher all-cause mortality at 1, 3, and 5 years in a large propensity-matched US electronic health record cohort, with excess risk varying by sex, race/ethnicity, and age.
preclinical
Form and function of actin impacts actin health and aging.
Genetic or pharmacologic disruption of actin and key actin-binding proteins shortens lifespan and worsens multiple aging hallmarks in a model organism, while mild actin stabilization with jasplakinolide modestly extends lifespan, and human ACTN3 polymorphisms correlate with age-related gait-speed decline.
observational
Why the mortality penalty of smoking is rising over time.
The nearly 50% rise in smoking’s age-controlled mortality penalty from 1987–1990 to 2012–2013 is driven largely by changes in the age distribution of smokers, even as more recent smoker cohorts show lower education, worse health, and greater psychological distress.
review
Multidimensional Regulatory Network of Cellular Senescence: From Mechanisms to Theranostics.
Cellular senescence is governed by a multidimensional regulatory network (p53/p21, p16/RB, mitochondrial stress, cGAS-STING, and mTOR-driven SASP) that can be targeted with integrated theranostic strategies for detection and clearance, though clinical translation is still limited by cell heterogeneity, off-target toxicity, and missing standardized biomarkers.
review
Senolytics for Cancer treatment: complexities and opportunities.
Senolytics for therapy-induced senescent tumor cells face major translational limits—variable efficacy by tumor background, proliferative recovery risk, adverse effects, and inability to spare beneficial senescent cells—while immune-based approaches (nanovaccines, CAR-T) are proposed as more selective alternatives needing validation.
observational
Factors affecting muscle strength, muscle mass, physical performance, and sarcopenia in middle-aged menopausal women in Taiwan: A cross-sectional study.
Among middle-aged women in Taiwan, postmenopausal status, older age, and lower BMI, fat mass, lean mass, bone mineral content, waist circumference, and intracellular water were associated with poorer muscle strength, muscle mass, and physical performance and higher sarcopenia risk.